Clinical lactation studies. Acting on key recommendations over the last decade
Manson, J. E. et al. The Women’s Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA 331, 1748–1760 (2024).
Google Scholar
Byrne, J. J. & Spong, C. Y. “Is It Safe?” – The Many Unanswered Questions about Medications and Breast-Feeding. N. Engl. J. Med. 380, 1296–1297 (2019).
Google Scholar
Duggal, M., Sacks, L. & Vasisht, K. P. Eligibility criteria and clinical trials: An FDA perspective. Contemp. Clin. Trials 109, 106515 (2021).
Google Scholar
Vargesson, N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res. C. Embryo Today 105, 140–156 (2015).
Google Scholar
Verstegen, R. H. J. & Ito, S. Drugs in lactation. J. Obstet. Gynaecol. Res. 45, 522–531 (2019).
Google Scholar
Court, R. et al. Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis. Br. J. Clin. Pharmacol. 88, 3548–3558 (2022).
Google Scholar
Hawcutt, D. B. et al. Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis. Br. J. Clin. Pharmacol. 82, 1601–1612 (2016).
Jordan, S. et al. Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert. Int. Breastfeed. J. 17, 55 (2022).
Google Scholar
FDA. FDA Postmarketing Requirements in Pregnant and Lactating Women: Past, Present, and Future (Center for Drug Evaluation and Research, US Food and Drug Administration, 2021).
Avachat, C., Younis, I. R. & Birnbaum, A. K. Characterization of the US Food and Drug Administration Post-Marketing Commitments and Requirements for Pregnancy and Lactation. Clin. Pharm. Ther. 114, 1238–1242 (2023).
Google Scholar
Patel, A. et al. Availability of safe and effective therapeutic options to pregnant and lactating individuals following the US FDA pregnancy and lactation labeling rule. J. Pediatr. 259, 113342 (2023).
Google Scholar
Waitt, C. J., Garner, P., Bonnett, L. J., Khoo, S. H. & Else, L. J. Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies. J. Antimicrob. Chemother. 70, 1928–1941 (2015).
Google Scholar
Ojara, F. W., Kawuma, A. N. & Waitt, C. A systematic review on maternal-to-infant transfer of drugs through breast milk during the treatment of malaria, tuberculosis, and neglected tropical diseases. PLoS. Negl. Trop. Dis. 17, e0011449 (2023).
Google Scholar
Beardmore, K. S., Morris, J. M. & Gallery, E. D. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens. Pregnancy 21, 85–95 (2002).
Google Scholar
Davanzo, R., Copertino, M., De Cunto, A., Minen, F. & Amaddeo, A. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed. Med. 6, 89–98 (2011).
Google Scholar
den Besten-Bertholee, D., van der Meer, D. H. & Ter Horst, P. G. J. Quality of lactation studies investigating antidepressants. Breastfeed. Med. 14, 359–365 (2019).
Google Scholar
Begg, E. J., Duffull, S. B., Hackett, L. P. & Ilett, K. F. Studying drugs in human milk: time to unify the approach. J. Hum. Lact. 18, 323–332 (2002).
Google Scholar
Eke, A. C. et al. Optimizing pharmacology studies in pregnant and lactating women using lessons from HIV: A consensus statement. Clin. Pharm. Ther. 110, 36–48 (2021).
Google Scholar
FDA. Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies: Draft Guidance for Industry (US Food and Drug Administration, 2024) 6 June 2024. Contract No.: FDA-2021-D-0789.
FDA. Clinical Lactation Studies: Considerations for Study Design. Guidance for Industry (US Department for Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); 2019). Contract No.: 24840658dft.docx.
Illamola, S. M. et al. Inclusion of pregnant and breastfeeding women in research – efforts and initiatives. Br. J. Clin. Pharmacol. 84, 215–222 (2018).
Google Scholar
Jorgensen, S. C. J. et al. Inclusion of pregnant and breastfeeding women in nonobstetrical randomized controlled trials. Am. J. Obstet. Gynecol. Mfm. 4, 100700 (2022).
Google Scholar
Leung, F. et al. Eligibility and enrollment of pregnant and breastfeeding women in psychiatry randomized controlled trials. Arch. Women’s. Ment. Health 26, 353–359 (2023).
Google Scholar
ICH. Final Concept Paper E21: Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials (ICH, 2023).
FDA. Postmarketing Requirements and Commitments: Downloadable Database Fil (FDA, 2024).
Zeh, C. et al. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. PLoS Med. 8, e1000430 (2011).
Google Scholar
Fogel, J. et al. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clin. Infect. Dis. 52, 1069–1076 (2011).
Google Scholar
FDA. Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act (US Food and Drug Administration, 2023). Contract No.: FDA-2005-D-0460.
ICH E11A Guideline on pediatric extrapolation. (2025).
Witzel, S. J. Lactation and the use of biologic immunosuppressive medications. Breastfeed. Med. 9, 543–546 (2014).
Google Scholar
Nauwelaerts, N. et al. A comprehensive review on non-clinical methods to study transfer of medication into breast milk—a contribution from the ConcePTION project. Biomed. Pharmacother. 36, 111038 (2021).
Google Scholar
Byrne, J. J., Saucedo, A. M. & Spong, C. Y. Evaluation of drug labels following the 2015 pregnancy and lactation labeling rule. JAMA Netw. Open. 3, e2015094 (2020).
Google Scholar
Atkinson, H. C. & Begg, E. J. Prediction of drug distribution into human milk from physicochemical characteristics. Clin. Pharmacokinet. 18, 151–167 (1990).
Google Scholar
Fleishaker, J. C., Desai, N. & McNamara, P. J. Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat. J. Pharm. Sci. 76, 189–193 (1987).
Google Scholar
Jones, S., Al-Doori, F. & Fujiwara, R. Prediction of milk plasma ratio for amphoteric substances. Pharmacol. Res. Perspect. 11, e01042 (2023).
Google Scholar
Pansari, A., Pan, X., Almond, L. M. & Rowland-Yeo, K. A tutorial on physiologically based pharmacokinetic approaches in lactation research. CPT Pharmacomet. Syst. Pharmacol. 13, 1841–1855 (2024).
Google Scholar
Nauwelaerts, N. et al. Generic workflow to predict medicine concentrations in human milk using physiologically-based pharmacokinetic (PBPK) modeling – a contribution from the ConcePTION project. Pharmaceutics 15, 1469 (2023).
Google Scholar
Anderson, P. O. & Sauberan, J. B. Modeling drug passage into human milk. Clin. Pharmacol. Ther. 100, 42–52 (2016).
Google Scholar
Ito, S. Drug therapy for breast-feeding women. N. Engl. J. Med. 343, 118–126 (2000).
Google Scholar
NIH. Drugs and Lactation Database (LactMed) [Available from: (2025).
Dodeja, P., Chaphekar, N., Caritis, S. N. & Venkataramanan, R. Optimizing drug therapy during pregnancy: a spotlight on population pharmacokinetic modeling. Expert. Opin. Drug Metab. Toxicol. 18, 1–18 (2024).
Alshogran, O. Y. et al. Drugs in human milk part 1: practical and analytical considerations in measuring drugs and metabolites in human milk. Clin. Pharmacokinet. 63, 561–588 (2024).
Google Scholar
FDA. Postapproval Pregnancy Safety Studies. Guidance for Industry. Draft Guidance (U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), 2019).
Fairlie, L. et al. Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards? J. Int. AIDS Soc. 22, e25372 (2019).
Google Scholar
Weld, E. D., Bailey, T. C. & Waitt, C. Ethical issues in therapeutic use and research in pregnant and breastfeeding women. Br. J. Clin. Pharmacol. 88, 7–21 (2021).
Google Scholar
Pan, X., Abduljalil, K., Almond, L. M., Pansari, A. & Yeo, K. R. Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example. CPT Pharmacomet. Syst. Pharmacol. 13, 386–395 (2024).
Google Scholar
Pansari, A., Faisal, M., Jamei, M. & Abduljalil, K. Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model. Biopharm. Drug Dispos. 43, 201–212 (2022).
Google Scholar
Anderson, P. O. & Momper, J. D. Clinical lactation studies and the role of pharmacokinetic modeling and simulation in predicting drug exposures in breastfed infants. J. Pharmacokinet. Pharmacodyn. 47, 295–304 (2020).
Google Scholar
Ito, S. Emerging research paradigm for infant drug exposure through breast milk. Curr. Pharm. Des. 25, 528–533 (2019).
Google Scholar
Kiguba, R., Olsson, S. & Waitt, C. Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa. Br. J. Clin. Pharmacol. 89, 491–509 (2023).
Google Scholar
Gribble, K., Mathisen, R., Ververs, M. T. & Coutsoudis, A. Mistakes from the HIV pandemic should inform the COVID-19 response for maternal and newborn care. Int. Breastfeed. J. 15, 67 (2020).
Google Scholar
Kuhn, L. & Aldrovandi, G. Survival and health benefits of breastfeeding versus artificial feeding in infants of HIV-infected women: developing versus developed world. Clin. Perinatol. 37, 843–862 (2010).
Google Scholar
WHO. Guidelines on HIV and infant feeding 2010 (WHO, 2010).
Waitt, C. et al. Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings. Lancet Hiv. 5, e531–e536 (2018).
Google Scholar
NIH. International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Network [Available from: (2025).
Thurin, N. H. et al. From Inception to ConcePTION: genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding. Clin. Pharmacol. Ther. 111, 321–331 (2022).
Google Scholar
The MPRINT Hub. Available from: (2024).
Waitt, C. et al. Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs. J. Antimicrob. Chemother. 73, 1013–1019 (2018).
Google Scholar
Nakijoba, R. et al. Pharmacokinetics of drugs used to treat drug sensitive-tuberculosis in breastfeeding mother-infant pairs: An observational pharmacokinetic study. Wellcome Open Res. 8, 216 (2023).
Google Scholar
Nakijoba, R. et al. -Pharmacokinetics of drugs used to treat uncomplicated malaria in breastfeeding mother-infant pairs: An observational pharmacokinetic study. Wellcome Open Res. 8, 12 (2023).
Google Scholar
Nakijoba, R. et al. Recruitment of pregnant and breastfeeding women in pharmacokinetic studies: strategies, opportunities, barriers, and recommendations. BMC Res. Notes 17, 312 (2024).
Google Scholar
Waitt, C. et al. Attaining equity of access to research: perspective on research in pregnancy and breastfeeding following Dolores Shockley lecture at ASCPT2024. Clin. Pharmacol. Ther. 116, 1506–1512 (2024).
Google Scholar
Nalugga, E. A. et al. It Takes a village; involvement of village health teams to develop tools and resources to communicate about antiretroviral use in pregnancy and breastfeeding at community level in Uganda. Wellcome Open Res. 9, 510 (2023).
Google Scholar
Deligiannidis, K. M. et al. Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry 78, 951–959 (2021).
Google Scholar
Deligiannidis, K. M. et al. Zuranolone concentrations in the breast milk of healthy, lactating individuals: results from a Phase 1 open-label study. J. Clin. Psychopharmacol. 44, 337–344 (2024).
Google Scholar
Korth-Bradley, J. M. et al. Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women. Antimicrob. Agents Chemother. 55, 5200–5204 (2011).
Google Scholar
Wood, N. D. et al. The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation. PLoS Negl. Trop. Dis. 18, e0012351 (2024).
Google Scholar
Abla, N. et al. Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure. Malar. J. 23, 287 (2024).
Google Scholar
Quinney, S. K. et al. The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal-pediatric therapeutics research through data integration and pharmacometrics. Pharmacotherapy 43, 391–402 (2023).
Google Scholar
Website IMPAACT protocol. (2025).
Van Neste, A. et al. Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol-a contribution from the ConcePTION project. BMJ Paediatr. Open. 10, e002385 (2024).
Google Scholar
link
:max_bytes(150000):strip_icc()/teaforupsetstomach-b90729daf6b84c8ba34004984712f3cb.jpg "The #1 Tea to Soothe an Upset Stomach")
